Clinical Evidence: What the Research Shows About Both Treatments
Is Wegovy or Mounjaro Better: Understanding the Clinical Evidence
When evaluating whether Wegovy or Mounjaro is better suited to your needs, the clinical evidence provides crucial insights into how each treatment performs. Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity. The recent SELECT study also revealed a 20% reduction in major cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro, containing tirzepatide, operates through a dual mechanism targeting both GIP and GLP-1 receptors, whilst Wegovy focuses specifically on GLP-1 pathways. Both treatments require careful medical supervision and are only available as prescription-only medicines through licensed UK pharmacies. The decision between these options should always be made in consultation with a qualified prescriber who can assess your individual circumstances, medical history, and treatment goals.
Is Wegovy or Mounjaro Better Value: UK Pricing and Bundle Options
Understanding the cost implications helps determine whether Wegovy or Mounjaro offers better value for your specific situation. Wegovy is available at EverydayMeds starting from £79.99 for the initial 0.25mg dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our bundle options provide convenient multi-month supplies, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
New customers benefit from code FIRST40 applied at checkout, whilst returning patients use DOSE25 for ongoing orders. These discount codes are factored into our listed prices, ensuring transparency throughout your treatment journey. Bundle purchases offer the advantage of Reliable Supply continuity and reduced ordering frequency, particularly important during the dose escalation phase when consistent progression is essential for optimal results.
Wegovy vs Mounjaro: What Clinical Trials Tell Us About Effectiveness
The STEP trial programme provides robust evidence for Wegovy's effectiveness, with Wilding et al. (NEJM, 2021) documenting significant weight reductions across multiple study populations. STEP 3 demonstrated approximately 16% average weight loss when combined with intensive behavioural therapy, whilst STEP 5 showed sustained results of around 15.2% at two years, indicating long-term efficacy when treatment is maintained.
Clinical assessments must consider that trial results represent averages across diverse populations and cannot predict individual outcomes. Both Wegovy and Mounjaro have completed extensive regulatory review by the MHRA, with each receiving approval for specific indications in weight management alongside lifestyle modifications.
How Wegovy Works: The GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones in your body. This mechanism works by slowing gastric emptying, which helps you feel fuller for longer periods after eating smaller meals. The treatment also acts on appetite centres in the brain, potentially reducing food cravings and the desire to eat between meals. Additionally, Wegovy may influence reward pathways associated with food intake, supporting behavioural changes essential for sustainable weight management. The once-weekly injection schedule using the FlexTouch pen system provides consistent medication levels throughout the week, supporting steady appetite regulation.
Is Wegovy or Mounjaro Better for Your Lifestyle: Ordering Process
Accessing either treatment through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture essential medical information for prescriber review. Our qualified prescribers evaluate your suitability for treatment within standard 3 working days, with express 24-hour review available when needed. Once approved, your medication ships via next-day delivery using specialised cold-chain packaging to maintain the required temperature throughout transit. This process ensures you receive genuine, properly stored medication whilst meeting all regulatory requirements for prescription-only medicines. Regular follow-up assessments help monitor your progress and adjust treatment as necessary.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Storage requirements can influence whether Wegovy or Mounjaro better suits your lifestyle, particularly if you travel frequently or have limited refrigeration access. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Before first use, both medications require storage between 2-8°C in your refrigerator. The Wegovy FlexTouch pen system includes dose escalation over 16 weeks, starting at 0.25mg and gradually increasing to the maintenance dose of 2.4mg. This gradual progression helps minimise potential side effects whilst allowing your body to adapt to the medication.
UK Weight Loss Results: Real-World Considerations for Wegovy and Mounjaro
When evaluating whether Wegovy or Mounjaro produces better weight loss results in UK patients, it's essential to understand that individual responses vary significantly based on adherence, lifestyle factors, and biological differences. Real-world data collection continues through post-marketing surveillance, providing ongoing insights into effectiveness across diverse UK populations. Both treatments require commitment to lifestyle modifications, including sustained dietary changes and increased physical activity levels.
The UK healthcare environment, with NICE guidance TA875 recommending Wegovy alongside specialist weight management support, emphasises the importance of comprehensive treatment approaches rather than medication alone. Success with either treatment depends heavily on consistent administration, regular monitoring, and ongoing support from healthcare professionals throughout your weight management journey.
Making Your Decision: Wegovy or Mounjaro Through EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical profile and lifestyle requirements. Our clinical team, operating under GPhC registration #9012878, provides expert guidance throughout the assessment process, ensuring you receive the most appropriate prescription-only medicine for your circumstances. Starting your consultation today allows you to explore these evidence-based treatment options with professional support. Use code FIRST40 for new customers or DOSE25 for returning patients when placing your order at https://everydaymeds.co.uk/collections/wegovy. Remember that sustainable weight management requires ongoing commitment to healthy lifestyle choices alongside any prescribed medication.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
